Get the Stockscreener App
2.80
2.19%
0.06
After Hours:
2.86
0.06
+2.14%
Accendra Health Inc stock is traded at $2.80, with a volume of 1.27M.
It is up +2.19% in the last 24 hours and up +0.00% over the past month.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
See More
Previous Close:
$2.74
Open:
$2.74
24h Volume:
1.27M
Relative Volume:
0.67
Market Cap:
$216.57M
Revenue:
$10.42B
Net Income/Loss:
$-38.77M
P/E Ratio:
-5.4902
EPS:
-0.51
Net Cash Flow:
$323.54M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+4.09%
1Y Performance:
-59.24%
1-Day Range:
$2.69
$2.82
1-Week Range:
$2.69
$2.82
52-Week Range:
$2.38
$9.55
Accendra Health Inc Stock (OMI) Company Profile
Name
Accendra Health Inc
Sector
Industry
Phone
(804) 723-7000
Address
10900 NUCKOLS ROAD, GLEN ALLEN, VA
Compare OMI vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMI
Accendra Health Inc
|
2.80 | 216.57M | 10.42B | -38.77M | 323.54M | -0.51 |
MCK
Mckesson Corp
|
766.50 | 90.72B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
265.44 | 51.51B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
200.61 | 46.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
73.50 | 8.34B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.51 | 1.37B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (OMI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | UBS | Buy → Neutral |
| Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-26-22 | Resumed | Citigroup | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-30-22 | Resumed | JP Morgan | Underweight |
| Dec-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-01-18 | Reiterated | Barclays | Underweight |
| Oct-31-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-08-18 | Initiated | Barclays | Underweight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Dec-19-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-01-17 | Upgrade | Robert W. Baird | Underperform → Neutral |
| Nov-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Apr-21-16 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-16-16 | Initiated | Credit Suisse | Underperform |
| Dec-07-15 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Accendra Health Inc Stock (OMI) Latest News
Accendra Health (ACH) shares jump after first-quarter earnings beat - MSN
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health, Inc. 8-K Filing Details: Company Information, Address, and Voting Results (May 14, 2026) - Minichart
Accendra Health Shareholders Approve Amended Omnibus Incentive Plan - TipRanks
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:ACH) 2026-05-14 - Seeking Alpha
ACCENDRA HEALTH INCANNOUNCES OVER $1.5 BLN BALANCE SHEET OPTIMIZATION DEAL - Moomoo
Accendra Health 1Q Adj Loss/Shr 4c >ACH - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut - Investing.com India
Accendra Health Inc (ACH) Q1 2026 Earnings Call Highlights: Navi - GuruFocus
Accendra Health To Effectuate Balance Sheet Optimization Transaction in Near Term >ACH - Moomoo
Accendra Health Shares Gain on Narrowed Loss, Adjusted EPS Beat - Moomoo
Accendra Health Q1 2026 slides: margins surge post-split, debt cut By Investing.com - Investing.com South Africa
Accendra Health cuts debt by $100M, extends maturities, but slow growth keeps EBITDA outlook cautious. - Pluang
Healthcare Firm Accendra Inks Discount Debt Exchange, New Funds - Bloomberg.com
Accendra Health Makes Progress Addressing Its Debt Load (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Q1 2026 Earnings Transcript - AOL.com
Accendra Health earnings beat by $0.06, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Reports Q1 2026 Financial Results and Announces $1.5 Billion Balance Sheet Optimization Transaction - Minichart
Accendra Health 2026: Leading Home-Based Care Provider with Strong Financials, Growth Strategy, and Capital Structure Optimization - Minichart
Accendra Health 1Q 2026: Revenue $627.78M, EPS ($0.08) — 10-Q Summary - TradingView
Accendra Health (ACH) Q1 2026 loss, payor exit and major debt refi plan - Stock Titan
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 - Investing.com UK
Accendra Health (ACH) Q1 Earnings Show Mixed Results - GuruFocus
Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat - Yahoo Finance
Accendra Health 1Q Loss/Shr 8c >ACH - Moomoo
Earnings call transcript: Accendra Health beats EPS expectations in Q1 2026 By Investing.com - Investing.com South Africa
Accendra Health reports Q1, announces $1.5B optimization - HME News
Accendra Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Accendra Health reports Q1 EPS (4c) vs. 29c last year - TipRanks
Q1 2026 Accendra Health Inc Earnings Call Transcript - GuruFocus
Accendra Health (NYSE:ACH) Beats Q1 Estimates and Unveils $1.5B Debt Restructuring - ChartMill
Accendra Health Reports Q1 Loss, Launches Balance Sheet Plan - TipRanks
Accendra Health stock soars nearly 10% on first quarter earnings beat - Investing.com Australia
Accendra Health stock soars nearly 10% on first quarter earnings beat By Investing.com - Investing.com South Africa
Accendra Health (ACH) reworks debt with $326M 9% notes, $300M revolver and exchanges - Stock Titan
Accendra Health (NYSE: ACH) unveils $1.5B balance sheet overhaul with Q1 results - Stock Titan
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction - marketscreener.com
Accendra Health (ACH) Stock News & Updates - Stock Titan
Owens & Minor Q1 2026 earnings preview - MSN
MSN Money - MSN
ACH Stock Price, Quote & Chart | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Why Accendra (ACH) business model holds up in any market (Investor Interest) 2026-05-08Community Trade Ideas - newser.com
Accendra Health Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Accendra Health Inc Stock (OMI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
4.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):